Entrada Therapeutics Inc (TRDA)
14.32
+0.07
(+0.49%)
USD |
NASDAQ |
Jul 01, 16:00
14.30
-0.02
(-0.14%)
After-Hours: 20:00
Entrada Therapeutics Free Cash Flow: -93.90M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -93.90M |
| December 31, 2023 | 134.19M |
| September 30, 2023 | 111.17M |
| June 30, 2023 | 108.81M |
| March 31, 2023 | 126.64M |
| Date | Value |
|---|---|
| December 31, 2022 | -96.67M |
| September 30, 2022 | -90.52M |
| June 30, 2022 | -77.11M |
| March 31, 2022 | -67.78M |
| December 31, 2021 | -55.44M |
Free Cash Flow Range, Past 5 Years
-96.67M
Minimum
Dec 2022
134.19M
Maximum
Dec 2023
-0.0622M
Average
-61.61M
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals Inc | 81.59M |
| Vertex Pharmaceuticals Inc | 3.479B |
| Sarepta Therapeutics Inc | -653.88M |
| PTC Therapeutics Inc | -199.47M |
| GlycoMimetics Inc | -33.81M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.52M |
| Cash from Investing (Quarterly) | 26.15M |
| Cash from Financing (Quarterly) | 0.206M |
| Free Cash Flow Per Share (Quarterly) | -0.7576 |
| Free Cash Flow to Equity (Quarterly) | -26.36M |
| Free Cash Flow to Firm (Quarterly) | -26.36M |
| Free Cash Flow Yield | -19.30% |